Company / Cash & Equivalents
Anterix Inc. Cash & Equivalents History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$47.4M
FY2025
5-year range
$47.4M / $117.5M
FY2021-FY2025
Trend
-21.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash & Equivalents has fluctuated over the past 10 years, ranging from $45,679 in FY2016 to $153M in FY2017.
Based on SEC 10-K filings.
$47M in FY2025 with a 5-year CAGR of -19.2%.
Declined from $106M to $47M over the past 2 years.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- -23.5%
- 5-Year CAGR
- -19.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -19.2%, indicating a declining trend.
- In FY2025, cash & equivalents decreased 21.8% year-over-year.
- Peak cash & equivalents was recorded in FY2017.
- Lowest cash & equivalents in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -0.55 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $47.4M | -21.8% |
| FY2024 | $60.6M | -42.6% |
| FY2023 | $105.6M | +0.0% |
| FY2022 | $105.6M | -10.1% |
| FY2021 | $117.5M | -14.5% |
| FY2020 | $137.5M | +79.2% |
| FY2019 | $76.7M | -38.2% |
| FY2018 | $124.1M | -19.1% |
| FY2017 | $153.5M | +335859.6% |
| FY2016 | $45.7K | -76.6% |
As of FY2025 · SEC Form 10-K · Last checked Jun 24, 2026